In the Zone: clinical development for oncology
Next generation sequencing panels are useful tools for diagnostics, hereditary risk assessment, prognosis and treatment selection and support the delivery of personalized treatment for cancer to help maximize patients’ response to therapy. However, researchers are met with significant challenges during drug development and data interpretation.
PODCAST
Precision oncology: an interview with Karina Eterovic
Dive into our podcast with Karina Eterovic, R&D Director for Oncology Diagnostics at Eurofins Viracor (KS, USA). Karina gives her insight into the technological advancements made through the increased focus on precision oncology and explains the major challenges faced during drug development.
INFOGRAPHIC
Infographic: Comprehensive genomic profiling assays for oncological studies
Explore our breakdown of PanCancerIQTM, the next generation sequencing assay enabling comprehensive in-house genomic profiling of tumor samples. Discover what services are provided by this sequencing solution and the ways in which PanCancerIQTM supports oncology clinical trial testing.
RESOURCES
Exploring the application of comprehensive genomic profiling in oncology therapy development
Cell and gene therapy development for oncology: an interview with David Willoughby
In association with:
